Cargando…

Mechanisms of ADC Toxicity and Strategies to Increase ADC Tolerability

SIMPLE SUMMARY: Antibody-drug conjugates (ADC) are a rapidly expanding class of anti-cancer drugs, with twelve agents in current clinical use. Despite recent successes, many ADCs fail during clinical development due to excessive toxicities and unfavorable risk-benefit profiles. Even for those ADCs t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Toan D., Bordeau, Brandon M., Balthasar, Joseph P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913659/
https://www.ncbi.nlm.nih.gov/pubmed/36765668
http://dx.doi.org/10.3390/cancers15030713

Ejemplares similares